Objective:To validate the clinical safety and efficacy of trimebutine maleate(Cerekinon) in treatment of irritable bowel syndrome(IBS).

• 目的:临床验证马来酸曲美布汀(舒丽启能)治疗肠易激综合征(IBS)的疗效及安全性。